HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease].

AbstractOBJECTIVE:
To evaluate, using pulmonary function tests, the effectiveness of formoterol as a bronchodilator at 30 min after its administration in patients with poorly reversible COPD.
METHODS:
A prospective study including 40 COPD patients not responding to the short-acting bronchodilator used in the spirometric test-variation of less than 200 mL and less than 7% of predicted in forced expiratory volume in one second (FEV1). All patients were classified as having stage II, III, or IV COPD (Brazilian Thoracic Society/Global Initiative for Chronic Obstructive Lung Disease) and presented FEV1 < 70% of predicted value. The patients were randomized into two groups of 20, with similar clinical characteristics, receiving, via a dry powder inhaler, either formoterol or a placebo. The pulmonary function testing (plethysmography) was repeated at 30 min after formoterol or placebo administration.
RESULTS:
In the formoterol group, the mean values obtained for FEV1, inspiratory capacity, and forced vital capacity were significantly greater than those obtained in the placebo group (p = 0.00065, p = 0.05, and p = 0.017, respectively), whereas that obtained for airway resistance was significantly lower (p = 0.010). Less pronounced differences were observed for residual volume, vital capacity and specific airway conductance, which were lower, higher and higher, respectively, in the formoterol group.
CONCLUSIONS:
In COPD patients not responding to the short-acting bronchodilator used in the spirometric test, formoterol promoted significant improvement in lung function at 30 min after of administration. Further studies are required to confirm whether formoterol can also be used as a medication for immediate relief of symptoms in COPD.
AuthorsAdalberto Sperb Rubin, Fábio José Fabrício de Barros Souza, Jorge Lima Hetzel, José da Silva Moreira
JournalJornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia (J Bras Pneumol) Vol. 34 Issue 6 Pg. 373-9 (Jun 2008) ISSN: 1806-3756 [Electronic] Brazil
Vernacular TitleResposta broncodilatadora imediata ao formoterol em doença pulmonar obstrutiva crônica com pouca reversibilidade.
PMID18622504 (Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Bronchodilator Agents
  • Ethanolamines
  • Placebos
  • Formoterol Fumarate
Topics
  • Administration, Inhalation
  • Aged
  • Aged, 80 and over
  • Bronchodilator Agents (therapeutic use)
  • Drug Resistance
  • Epidemiologic Methods
  • Ethanolamines (therapeutic use)
  • Female
  • Forced Expiratory Volume (drug effects, physiology)
  • Formoterol Fumarate
  • Humans
  • Male
  • Middle Aged
  • Placebos
  • Plethysmography
  • Pulmonary Disease, Chronic Obstructive (drug therapy, physiopathology)
  • Spirometry
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: